查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球血液气体和电解质分析仪市场 -2023-2030
市场调查报告书
商品编码
1374824

全球血液气体和电解质分析仪市场 -2023-2030

Global Blood Gas and Electrolyte Analyzers Market -2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

血气分析仪从注射器中吸出血液并测量 pH 值以及氧气和二氧化碳的分压。也计算碳酸氢盐浓度。这些结果通常可在五分钟内解释。

电解质分析仪是一种专门的医疗设备，旨在测量生物样本（通常是血液或血清）中的电解质浓度。电解质是必需离子，包括钠（Na+）、钾（K+）、氯（Cl-）、碳酸氢盐（HCO3-）和钙（Ca2+），在人体内的各种生理过程中发挥着至关重要的作用。准确测量这些电解质水平对于诊断和管理各种医疗状况至关重要。

市场动态：驱动因素与限制因素

科技进步的崛起

对于急诊和重症监护环境中的患者来说，一个至关重要的因素是他们快速变化的生理状态，这种状态可能会迅速恶化，需要立即诊断和临床决策以改善患者的治疗结果。护理点检测 (POCT) 是重症监护环境中的一项重大进步，旨在提供分散的、以患者为中心的医疗保健。快速取得血液测量结果，尤其是血液气体和电解质，可以带来更好的临床结果。

例如，2023年6月，烟台必安生物科技有限公司的i-Check手持式血气电解质分析仪采用了微流控和电化学检测技术。其一次性试剂盒包括塑胶基板、多生物感测器阵列、校准袋、样品注射端口和废物室。值得注意的是，多生物感测器阵列是透过网版印刷生产的。所使用的印刷油墨材料仅包含碳、银和绝缘材料，不含任何贵金属，与其他製造商相比，大大降低了生产成本。

此外，用于治疗癌症和糖尿病等慢性疾病的医疗保健支出的增加预计将在预测期内推动市场成长。这一增长表明重症监护病房和急诊科患者数量的增加，导致对血液气体和电解质分析的需求不断增长。相关组织和政府不断参与透过鼓励患者定期接受诊断检查来减少医疗保健支出的计划。

市场动态：克制

由于经典血气分析需要动脉血液样本，因此在样本采集过程中出现了许多挑战。例如，使用特殊的气密注射器来避免样本与外部空气混合。此外，血液样本在采集后必须立即充分混合，否则会发生沉淀，导致样本不均匀。

此外，市场上的一些主要限制因素包括缺乏熟练的专业人员、分析仪的成本、报销问题和复杂的法规。

有关此报告的更多详细资讯 - 索取样品

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按产品类型分類的片段
  • 按模态分類的片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 科技进步的崛起
      • 慢性病盛行率上升
    • 限制
      • 与样本采集相关的挑战
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按产品类型

  • 血气分析仪
  • 电解质分析仪
  • 组合分析仪
  • 其他的

第 8 章：按形态

  • 桌上型
  • 便携的

第 9 章：最终用户

  • 医院
  • 集中实验室
  • 护理点
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Abbott Point of Care Inc
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Siemens Healthcare Private Limited
  • Cornley Hi-tech Co., LTD
  • Radiometer Medical ApS
  • Chengdu Seamaty Technology Co., Ltd
  • EDAN Instruments, Inc
  • ERBA Diagnostics Mannheim GmbH
  • F Hoffman La Roche Ltd
  • Medica Corporation
  • i-SENS, Inc

第 13 章：附录

简介目录
Product Code: MD7248

Overview

Blood gas analyzers aspirate blood from the syringe and measure pH and the partial pressures of oxygen and carbon dioxide. The bicarbonate concentration is also calculated. These results are usually available for interpretation within five minutes.

An electrolyte analyzer is a specialized medical device designed to measure the concentration of electrolytes in a biological sample, typically blood or serum. Electrolytes are essential ions, including sodium (Na + ), potassium (K + ), chloride (Cl-), bicarbonate (HCO3-), and calcium (Ca2 + ), that play crucial roles in various physiological processes within the human body. The accurate measurement of these electrolyte levels is vital for diagnosing and managing a wide range of medical conditions.

Market Dynamics: Drivers and Restraints

Rise in technological advancements

A vital factor for patients in emergency and critical care settings is their rapidly changing physiological state, which can deteriorate quickly and necessitate immediate diagnosis and clinical decisions for improving patient outcomes. Point-of-care testing (POCT) is a significant advancement in critical care settings, designed to provide decentralized, patient-centred healthcare. Quick access to blood measurements, especially blood gases, and electrolytes, can lead to better clinical outcomes.

For instance, in June 2023, i-Check handheld blood gas electrolyte analyzer from B&E Biotechnology Co. Ltd. (Yantai, China) adopted microfluidic and electrochemical detection technology. Its single-use cartridge includes a plastic substrate, a multi-biosensor array, a calibrator pouch, a sample injection port, and a waste chamber. Notably, the multi-biosensor array is produced by silk-screen printing. The printing ink materials used comprise only carbon, silver, and insulation, without any noble metal, which significantly lowers the production cost compared to other manufacturers.

Furthermore, increasing healthcare expenditure for the treatment of chronic diseases, such as cancer and diabetes, is expected to drive market growth over the forecast period. This increase indicates a rise in the number of patients in critical care units and emergency departments, which has led to the growing need for blood gas and electrolyte analysis. Pertinent organizations and governments are constantly engaging in programs to reduce healthcare expenditure by encouraging patients to undergo regular diagnostic examinations.

Market Dynamics: Restraint

Since classical blood gas analysis requires an arterial blood sample, many challenges arise during sample collection. For example, special gas-tight syringes are used to avoid adulteration of the sample with outside air. Furthermore, the blood sample must be properly mixed immediately after collection, otherwise, sedimentation will occur, resulting in an inhomogeneous sample.

Also, some of the major restraining factors in the market include the lack of skilled professionals, the cost of the analyzer, reimbursement issues, and complicated regulations.

For more details on this report - Request for Sample

Segment Analysis

The global blood gas and electrolyte analyzers is segmented based on product type, modality, end-user and region.

The blood gas analyzers from the product type segment accounted for approximately 41.2% of the market share

The blood gas analyzers from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. Blood gas analyzers are used to measure combinations of pH, blood gas (i.e. pCO2 and pO2), electrolytes, and metabolite parameters from whole blood samples. Blood conservation is an important initiative in every clinical diagnostic lab or critical care facility. Therefore, a highly accurate blood gas analyzer can streamline work processes and reduce errors with minimum maintenance.

For instance, in June 2022, Sysmex America Inc., a leading name in the diagnostics solutions marketplace, received FDA clearance for the addition of a new feature to its N-10 Automated Hematology Analyzer with Blood Bank mode. This is the first automated analyzer to be cleared for residual WBC counting.

Moreover, in April 2021, Siemens Healthiness launched the epoc blood analysis system, It is a handheld, wireless solution with complete blood gas, a basic metabolic panel, and hematocrit and lactate on a single room temperature-stable test card, delivering patient-side results in less than 1 minute. It aids in supporting COVID-19 response efforts, where blood gas testing plays a critical role in managing infected patients.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the large presence of domestic and international medical device companies from both the developed and emerging markets boost the demand and growth of analyzes in the country. The region is expected to witness high demand for products such as arterial blood gas machines, electrolyte analyzer machines, and blood oxygen analyzers.

For instance, in March 2020, Siemens Healthineers stated that it won FDA clearance for its RapidPoint 500e blood gas analyzer for diagnosing and monitoring people in the intensive care unit, operating room or emergency room.

RapidPoint 500e is designed to generate blood gas, electrolyte, metabolite, CO-oximetry and neonatal bilirubin results that are then used to diagnose and monitor critically ill patients. The analyzer can be used in COVID-19 response efforts, where blood gas testing helps in managing infected patients and monitoring their respiratory distress.

COVID-19 Impact Analysis

The COVID-19 pandemic positively impacted the blood gas and electrolyte analyzers market. As amid the pandemic several surgeries were postponed, and non-emergency hospitalizations were cancelled impacted the market moderately.

However, there was a rise in the hospitalization rate of people suffering from COVID-19. Surging cases of the COVID-19 pandemic have increased demand for blood gas and electrolyte analyzers in hospitals, clinics, point of care centers will positively influence the industry growth.

Competitive Landscape

The major global players in the blood gas and electrolyte analyzers market include: Abbott Point of Care Inc., Siemens Healthcare Private Limited, Cornley Hi-tech Co., LTD, Radiometer Medical ApS, Chengdu Seamaty Technology Co., Ltd, EDAN Instruments, Inc., ERBA Diagnostics Mannheim GmbH, F Hoffman La Roche Ltd, Medica Corporation, i-SENS, Inc and among others.

Key Developments

  • In September 2021, Sensa Core Medical Instrumentation stated that the availability of its flagship Blood Gas Analyzer ST-200CC blood gas analyzers - Ultra Smart for hospitals, clinics and diagnostics centres through its network in India.
  • In May 2020, Roche stated the CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm.
  • In January 2020, Siemens Healthineers stated that its latest critical care testing solution, the RAPIDPoint 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration. The analyzer generates blood gas, electrolyte, metabolite, CO-oximetry, and neonatal bilirubin results, which are used to diagnose and monitor critically ill patients in the intensive care unit, operating room, or emergency room.

Why Purchase the Report?

  • To visualize the global blood gas and electrolyte analyzers market segmentation-based product type, modality, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of blood gas and electrolyte analyzers market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global blood gas and electrolyte analyzers market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Modality
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. Rise in the technology advancements
      • 4.1.1.2. Rise in prevalence of chronic diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Challenges associated with sample collection
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Blood Gas Analyzer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Electrolyte Analyzer
  • 7.4. Combined Analyzer
  • 7.5. Others

8. By Modality

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.1.2. Market Attractiveness Index, By Modality
  • 8.2. Benchtop*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Portable

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Centralized Laboratories
  • 9.4. Point of Care
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Abbott Point of Care Inc
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Siemens Healthcare Private Limited
  • 12.3. Cornley Hi-tech Co., LTD
  • 12.4. Radiometer Medical ApS
  • 12.5. Chengdu Seamaty Technology Co., Ltd
  • 12.6. EDAN Instruments, Inc
  • 12.7. ERBA Diagnostics Mannheim GmbH
  • 12.8. F Hoffman La Roche Ltd
  • 12.9. Medica Corporation
  • 12.10. i-SENS, Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us